Integrated photonics is a technology that will play a decisive role in the coming years in the field of innovative healthcare solutions. In the long term, this technology has the potential to make healthcare many times more accessible and affordable. At Enzyre, they recognise the opportunities offered by integrated photonics.
What is photonics?
Photonics is similar to ‘conventional’ electronics. However, instead of electrons, photonics uses photons (‘particles of light’) to transmit information. Photonic technology detects, generates, transmits and processes light. Current applications include solar cells, sensors and fibre-optic networks.
In addition, there are photonic chips: known in technical jargon as Photonic Integrated Circuits (PICs). These integrate various photonic and often electronic functions into a single microchip. This enables the creation of smaller, faster and more energy-efficient devices. As they are manufactured in a similar way to traditional chips, mass production is also within reach. This results in a fall in prices.
The promise is that photonics will make healthcare more accessible and cheaper. More accessible, because patients no longer need to go to hospital for non-urgent tests. They can carry out the tests themselves at home. Photonics also makes it possible to weld and cut using a laser beam. It can help measure blood oxygen saturation, scan a suspicious mole or perform an ECG. Apart from that, it is also cheaper for society to detect diseases at an early stage – and to prevent them.
Technology for haemophilia patients
Several Dutch start-ups have a very clear understanding of the opportunities offered by photonics, writes Innovation Origins. In collaboration with Photondelta, the platform highlights a number of start-ups working with this technology. One of these is Enzyre, based in Nijmegen. There, they are developing a device that analyses coagulation factor VIII in the blood. Waander van Heerde is the company’s director. He founded it in 2016 together with Guido Maertens.
Van Heerde was head of the specialist coagulation laboratory at Radboudumc for 17 years, where he still works two days a week: “Our platform technology will initially be used for haemophilia patients. These people have a deficiency of factor VIII in their blood, which puts them at high risk of bleeding. This can be treated very effectively with injections that allow patients to bring their FVIII levels back to the correct level themselves. With our device, patients can measure the extent of their Factor VIII deficiency at home. They can then quickly adjust it themselves with a supplementary injection, which stops the bleeding.”
Cheaper care through integrated photonics
Enzyre’s technology works by measuring the number of photons in the blood. Until now, this has been done using a sensor that operates on conventional chips. Van Heerde: “In the future, this can also be done using photonic sensors, making the process cheaper and faster. We will then also need less blood for testing.”
Van Heerde foresees a bright future for photonics in the healthcare sector. “Healthcare needs to become more affordable. This can be achieved with integrated photonics, because optical chips are faster, use less energy and are therefore more efficient. Thanks to photonics, the laboratory is no longer in the hospital; instead, we bring it to the patient in their living room.”
Image by Gerd Altmann via Pixabay


